drugset / Trial / NCT06454175
A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years
RandomizedParallel-groupDouble-blindPrevention
Summary
To evaluate the safety and tolerability of 15-valent HPV vaccine in 9-45year-old participants.
Timeline
- Start
- 2024-08-03
- Primary completion
- 2025-02-05
- Completion
- 2025-07-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 15-valent HPV Vaccine | Vaccine | — | Intramuscular |